Abstract
In a prospective, randomized, double-blind investigation of anticoagulant agents for prevention of deep vein thrombosis in patients undergoing operations at the lumbar-vertebral disc, 179 patients were randomly allocated to two groups. 87 patients received a fixed combination of low-molecular weight heparin 1,500 U-aPTT plus dihydroergotamine 0.5 mg (LMWH/DHE) once a day and additionally one injection of placebo per day, 92 patients received a fixed combination of sodium heparin 5,000 U plus dihydroergotamine 0.5 mg (HDHE) twice a day. Treatment was initiated two hours preoperatively in both groups and continued for at least seven days. Deep vein thrombosis (DVT), detected by the 125Iodine-labelled fibrinogen uptake-test, occurred in four patients treated with LMWH/DHE and in three patients with HDHE. In all seven patients phlebography was performed, confirming the diagnosis of DVT in one patient of the LMWH/DHE group and in two patients of the HDHE group, only. No increased bleeding was found in either group. Especially no neurological complications caused by epidural bleeding were observed. We therefore recommended to treat routineously all patients undergoing operations at the vertebral disc with antithrombotic agents. The advantages of the once daily regimen with low-molecular weight heparin include better patients' acceptance and less nursing time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adolf J, H Knee, JD Roder, E van de Flierdt, JR Siewert: Thromboembolieprophylaxe mit niedermolekularem Heparin in der Abdominalchirurgie. Dtsch med Wschr 114 (1989) 48–53
Cerrato D, C Ariano, F Fiacchina: Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49 (1978) 378–381
The European Fraxiparin Study (EFS) Group: Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 75 (1988) 1058–1063
Gruber UF, T Saldeen, T Brokop, B Eklöf, I Eriksson, I Goldie, L Gran, M Hohl, T Jonsson, S Kristersson, KG Ljungström, T Lund, H Maartman Moe, E Svensjö, D Thomson, J Torhorst, A Trippestad, M Ulstein: Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. Br med J 280 (1980) 69–72
Haas S, A Stemberger, H-M Fritsche, D Welzel, H Wolf, F Lechner, G Blümel: Prophylaxis of Deep Vein Thrombosis in High Risk Patients Undergoing Total Hip Replacement with Low Molecular Weight Heparin Plus Dihydroergotamine. Arzneim-Forsch/Drug Res 37 (II), 7: 839–843
Heilmann L, M Kruck, AE Schindler: Thromboseprophylaxe in der Gynäkologie: Doppelblind-Vergleich zwischen niedermolekularem (LMWH) und unfraktioniertem Heparin (UFH). Geburtsh Frauenheilk 49 (1989) 803–807
Hellstern P, R Kiehl, G von Blohn, M Köhler, U Meierhenrich, E Wenzel: Dose Response Relationships of Anticoagulant Activities After Subcutaneous Administration of Two Low Molecular Weight Heparins in Healthy Volunteers. Thrombosis and Haemostasis 56 (2) (1986) 225–228
Kakkar VV, PJ Fok, WJG Murray, T Paes, D Merenstein, R Dodds, R Farrell, RQ Crellin, EM Thomas, TR Morley, AJ Price: Heparin and Dihydroergotamine Prophylaxis against Thrombo-Embolism after Hip Arthroplasty. The Journal of Bone and Joint Surgery 67-B, 4 (1985) 538–542
Kakkar VV, AN Nicolaides, JTG Renney, JR Friend, MB Clarke: 125-I-labelled fibrinogen plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. Br J Surg 73 (1986) 697–700
Kakkar VV, MD Stringer, AR Hedges, CJ Parker, D Welzel, VP Ward, RM Sanderson, D. Cooper, S Kakkar: Fixed combinations of lowmolecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative thrombosis. Am J Surg 157 (1989) 413–418
Koller M, U Schoch, P Buchmann, F Largiader, A von Felten, PG Frick: Low molecular weight heparin (KABI 2165) as thromboprophylaxis in electice visceral surgery. Thromb and Haemostas 56 (1986) 243–246
Koppenhagen K, A Wiechmann, E Frey, H G Wenig, H Latka, H-V Zühlke, E Tank, J Hardieck, H Ernst and R Haring: Klinisch-experimentelle Ergebnisse mit Heparin-Dihydroergotamin. Dtsch med Wschr 102 (1977) 1374–1378
Powers SK, MSB Edwards: Prophylaxis of thromboembolism in the neurosurgical patient: a review. Neurosurgery 10 (1982) 509
Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An International Multicenter Trial. The Lancet II (1975) 45–51
Sagar S, JD Stamatakis, AF Higgins, D Nairn, FH Maffei, DP Thomas, VV Kakkar: Efficacy of low-dose heparin in prevention of extensive deepvein thrombosis in patients undergoing total hipreplacement. The Lancet (1976) 1151–1154
Sasahara AA, K Koppenhagen, R Häring, D Welzel, H Wolf: Low molecular weight heparin plus dihydroergotamine for prophylaxis of post-operative deep vein thrombosis. Brit J Surg 73 (1986) 697–700
Warning A, D Nies, H Wolf and D Welzel: Effects of low molecular weight heparin on coagulation parameters and bleeding time in healthy volunteers. Arzneim-Forsch/Drug Res 37 (1987) 847–849
Weber U, K Koppenhagen, H Mälzer, M Matthes: Unterschiedliche Wirksamkeit von zwei Präparaten mit niedermolekularem Heparin bei Patienten mit elektivem Hüftgelenksersatz. Langenbecks Arch Chir 376 (1991) 147–151
Wolf H, A Encke, S Haas, D Welzel: Comparison of Efficacy and Safety of Sandoz Low Molecular Weight Heparin and Unfractionated Heparin: Interim Analysis of a Multicenter Trial. Seminars in Thrombosis and Hemostasis 17 (1991) 4
Wolf H, D Welzel, H Kaiser, M Majer, D Schäfer, K-J Husfeldt, J Voigt, L Sunder-Plassmann: Bewertung der perioperativen Thromboembolie-Prophylaxe mit niedermolekularem Heparin und Dihydroergotamin. Arzneim-Forsch/Drug Res 48 (1988) 1516–1519
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Voth, D., Schwarz, M., Hahn, K. et al. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Neurosurg. Rev. 15, 289–294 (1992). https://doi.org/10.1007/BF00257808
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257808